Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27733906)

Published in United European Gastroenterol J on August 21, 2016

Authors

Raf Bisschops1, Miguel Areia2, Emmanuel Coron3, Daniela Dobru4, Bernd Kaskas5, Roman Kuvaev6, Oliver Pech7, Krish Ragunath8, Bas Weusten9, Pietro Familiari10, Dirk Domagk11, Roland Valori12, Michal F Kaminski13, Cristiano Spada10, Michael Bretthauer14, Cathy Bennett15, Carlo Senore16, Mário Dinis-Ribeiro17, Matthew D Rutter18

Author Affiliations

1: Department of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium.
2: Gastroenterology Department, Portuguese Oncology Institute, Coimbra, Portugal; Center for Health Technology and Services Research (CINTESIS), University of Porto, Porto, Portugal.
3: Institut des Maladies de l'Appareil Digestif, CHU de Nantes, Nantes, France.
4: Gastroenterology Department, University of Medicine and Pharmacy, Targu Mures, Romania.
5: Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
6: Endoscopy, Yaroslavl Regional Cancer Hospital, Yaroslavl, Russian Federation.
7: Klinik für Gastroenterologie und interventionelle Endoskopie, Barmherzige Brüder Regensburg, Regensburg, Germany.
8: NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust, Queen's Medical Centre Campus, Nottingham, UK.
9: Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, The Netherlands.
10: Digestive Endoscopy Unit, Agostino Gemelli University Hospital, Rome, Italy.
11: Department of Internal Medicine, Joseph's Hospital, Warendorf, Germany.
12: Department of Gastroenterology, Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire, UK.
13: Department of Health Management and Health Economy and KG Jebsen Centre for Colorectal Cancer, University of Oslo, Oslo, Norway; Department of Gastroenterological Oncology, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, and Medical Center for Postgraduate Education, Warsaw, Poland.
14: Department of Health Management and Health Economy and KG Jebsen Centre for Colorectal Cancer, University of Oslo, Oslo, Norway; Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
15: Centre for Technology Enabled Research, Coventry University, Coventry, UK.
16: CPO Piemonte, AOU Città della Salute e della Scienza, Torino, Italy.
17: Center for Health Technology and Services Research (CINTESIS), University of Porto, Porto, Portugal; Servicio de Gastroenterologia, Instituto Portugues de Oncologia Francisco Gentil, Porto, Portugal.
18: Department of Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK; School of Medicine, Durham University, Durham, UK.

Articles cited by this

(truncated to the top 100)

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76

Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med (2006) 10.52

The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc (2003) 8.43

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14

American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78

The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut (2013) 4.29

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ (2000) 4.21

Endoscopy in gastrointestinal bleeding. Lancet (1974) 4.02

Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy (2005) 3.92

Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet (1989) 3.84

The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology (2006) 3.80

Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc (2010) 3.74

Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut (2012) 3.30

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19

The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc (2006) 2.71

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy (2011) 2.64

Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol (2000) 2.58

Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49

Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy (2014) 2.35

Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol (2003) 2.34

Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2010) 2.24

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05

Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol (2008) 1.96

Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90

The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol (2008) 1.85

Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2015) 1.84

Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc (2000) 1.83

Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut (2003) 1.81

Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma. J Clin Gastroenterol (2003) 1.76

Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut (2010) 1.68

Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol (2008) 1.64

Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists. Gastrointest Endosc (2002) 1.61

Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol (2014) 1.58

Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer (1990) 1.58

Caustic ingestion in adults: the role of endoscopic classification in predicting outcome. BMC Gastroenterol (2008) 1.54

Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas. Dig Dis Sci (2013) 1.53

Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies. Gastrointest Endosc (2009) 1.52

Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg (2012) 1.50

Esophageal endoscopic dilations. J Pediatr Gastroenterol Nutr (2012) 1.50

Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology (2010) 1.48

The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc (2010) 1.46

Long-term results of endoscopic resection for type I gastric neuroendocrine tumors. J Surg Oncol (2013) 1.43

Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg (2005) 1.40

EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Gastrointest Endosc (2008) 1.39

ESGE recommendations for quality control in gastrointestinal endoscopy: guidelines for image documentation in upper and lower GI endoscopy. Endoscopy (2001) 1.35

The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol (2013) 1.33

Delayed perforation: a hazardous complication of endoscopic resection for non-ampullary duodenal neoplasm. Dig Endosc (2013) 1.25

Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy (2006) 1.24

Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol (1999) 1.24

Lugol's dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol (2005) 1.18

BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17

Endoscopic management of congenital esophageal stenosis. J Pediatr Surg (2011) 1.15

The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy (2015) 1.08

Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc (2012) 1.08

Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes. Surg Endosc (2013) 1.07

Endoscopic balloon dilatation of esophageal strictures in infants and children: 17 years' experience and a literature review. J Pediatr Surg (2003) 1.07

The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy. Cancer (1994) 1.06

Balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia. Br J Radiol (2003) 1.05

Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter (2010) 1.05

Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci (2003) 1.05

Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% lugol dye solution in patients with head and neck cancer. Head Neck (2000) 1.03

Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus (2008) 1.03

Endoscopic resection of duodenal neoplasms: a single-center study. Surg Endosc (2010) 1.02

Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc (2012) 1.00

Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: can classification be simplified? Endoscopy (2013) 1.00

Endoscopic resection of gastrointestinal lipomas: a single-center experience. Surg Endosc (2013) 0.99

Balloon dilation of anastomotic strictures secondary to surgical repair of esophageal atresia in a pediatric population: long-term results. J Vasc Interv Radiol (2006) 0.98

Balloon catheter dilatation of benign esophageal strictures in children. J Vasc Interv Radiol (2006) 0.97

Efficacy and long-term outcome of endoscopic treatment of sporadic nonampullary duodenal adenoma. Gut Liver (2010) 0.97

Therapeutic outcomes of endoscopic resection for superficial non-ampullary duodenal tumor. Dig Endosc (2014) 0.96

Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats. Gastrointest Endosc (2012) 0.96

Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia. Aliment Pharmacol Ther (2004) 0.96

Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol (2014) 0.94

Benign esophageal strictures in infants and children: results of Savary-Gilliard bougie dilation in 107 Indian children. Gastrointest Endosc (2001) 0.93

Corrosive esophageal injuries in children. A shortlived experience in Sierra Leone. Int J Pediatr Otorhinolaryngol (2007) 0.93

Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation. Dig Liver Dis (2008) 0.93

Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening. Dig Dis Sci (2014) 0.92

Endoscopic resection of sporadic duodenal adenomas: comparison of endoscopic mucosal resection (EMR) with hybrid endoscopic submucosal dissection (ESD) techniques and the risks of late delayed bleeding. Surg Endosc (2014) 0.91

The effect of an information brochure on patients undergoing gastrointestinal endoscopy: a randomized controlled study. Patient Educ Couns (2006) 0.91

Audit of a Barrett's epithelium surveillance database. Eur J Gastroenterol Hepatol (2004) 0.91

Perforation during esophageal dilatation: a 10-year experience. J Gastrointestin Liver Dis (2013) 0.90

Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies. Surg Endosc (2010) 0.90

Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Am J Med (2010) 0.89

Polyp morphology: an interobserver evaluation for the Paris classification among international experts. Am J Gastroenterol (2014) 0.89

Surveillance in Barrett's esophagus: an audit of practice. Dig Dis Sci (2009) 0.88

Incidence of macroscopically occult neoplasias in Barrett's esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am J Gastroenterol (2010) 0.88

Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett's esophagus surveillance program. Dig Dis Sci (2012) 0.88

Endoscopic resection of large sporadic non-ampullary duodenal polyps: efficacy and long-term recurrence. Surg Endosc (2014) 0.88

Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc (2012) 0.88

Method and timing of resection of superficial non-ampullary duodenal epithelial tumors. Dig Endosc (2014) 0.88

Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal. Endoscopy (2014) 0.87

Feasibility of endoscopic resection for sessile nonampullary duodenal tumors: a multicenter retrospective study. Gastroenterol Res Pract (2015) 0.87

Benign esophageal strictures: behaviour, pattern and response to dilatation. J Pak Med Assoc (2010) 0.87

Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol (2003) 0.87

Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience. World J Gastroenterol (2014) 0.86

Balloon catheter dilatation in children with congenital and acquired esophageal anomalies. J Pediatr Surg (2002) 0.86

Articles by these authors

Narrow band imaging does not reliably predict residual intestinal metaplasia after radiofrequency ablation at the neo-squamo columnar junction. Endoscopy (2014) 1.44

The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy (2015) 1.08

Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy (2016) 0.94

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy (2017) 0.86

The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. United European Gastroenterol J (2015) 0.81

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J (2017) 0.78

Reporting systems in gastrointestinal endoscopy: Requirements and standards facilitating quality improvement: European Society of Gastrointestinal Endoscopy position statement. United European Gastroenterol J (2016) 0.76

Requirements and standards facilitating quality improvement for reporting systems in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy (2016) 0.75

Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitis. Gastrointest Endosc (2017) 0.75